adriamycinol has been researched along with Hematologic Malignancies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernández de Gatta, Mdel M; García Sánchez, MJ; González López, F; Hernández-Rivas, JM; Pérez-Blanco, JS; Sayalero Marinero, ML | 1 |
1 other study(ies) available for adriamycinol and Hematologic Malignancies
Article | Year |
---|---|
Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Doxorubicin; Drug Monitoring; Drug Stability; Hematologic Neoplasms; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity | 2014 |